News Releases

Einstein and Montefiore Receive Accreditation for Interprofessional Continuing Education
Einstein’s 2020 Stem Cell Symposium Spotlights RNA Biology and Gene Editing
Einstein and Montefiore Present Research and Clinical Advances at American Society of Hematology Annual Meeting

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Liise-anne Pirofski

Liise-anne Pirofski, M.D.

Area(s) of expertise: Infectious diseasesPneumoniaImmunology

Dr. Pirofski studies innate and vaccine-induced immunity to disease-causing microbes, including Cryptococcus (the leading cause of fungal meningitis globally) and Pneumococcus (the leading cause of pneumonia in the United States and globally). She has described novel ways by… Learn more

Einstein in the News

Researchers Have Found a Way to Improve TB Vaccine

William Jacobs Jr., Ph.D., comments on a study in which high doses of the tuberculosis vaccine injected directly into the bloodstream of monkeys provided nearly complete immunity to the disease. Dr. Jacobs is professor of microbiology & immunology and of genetics and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.

More coverage on Dr. Jacobs Jr.

US News & World Report
Patients Often Bring Undetected 'Superbug' to the Hospital

Sarah Baron, M.D., comments on her study that found nearly one in 10 patients admitted to the hospital are already infected with Clostridioides difficile, a bacterium that causes severe diarrhea and 30,000 deaths each year in the U.S. and has long been thought to be acquired while in the hospital. Dr. Baron is assistant professor of medicine at Einstein and an internist at Montefiore.

Human Toxocariasis Widespread, Preventive Interventions Needed

Dr. Louis Weiss, M.D., M.P.H., discusses a study on the prevalence of human toxocariasis and notes that clinicians can provide advice to patients to help them avoid infection. Dr. Weiss is professor of medicine and of pathology and co-director of Einstein’s Global Health Center.

More coverage on Dr. Weiss


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog